FR2866031B1 - Chimere de virus pathogene emergent, medicament la contenant et utilisation en therapie antivirale - Google Patents

Chimere de virus pathogene emergent, medicament la contenant et utilisation en therapie antivirale

Info

Publication number
FR2866031B1
FR2866031B1 FR0401364A FR0401364A FR2866031B1 FR 2866031 B1 FR2866031 B1 FR 2866031B1 FR 0401364 A FR0401364 A FR 0401364A FR 0401364 A FR0401364 A FR 0401364A FR 2866031 B1 FR2866031 B1 FR 2866031B1
Authority
FR
France
Prior art keywords
chimer
same
medicament containing
antiviral therapy
pathogenic virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0401364A
Other languages
English (en)
Other versions
FR2866031A1 (fr
Inventor
David Francois Joseph Millet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0401364A priority Critical patent/FR2866031B1/fr
Publication of FR2866031A1 publication Critical patent/FR2866031A1/fr
Application granted granted Critical
Publication of FR2866031B1 publication Critical patent/FR2866031B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0401364A 2004-02-11 2004-02-11 Chimere de virus pathogene emergent, medicament la contenant et utilisation en therapie antivirale Expired - Lifetime FR2866031B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0401364A FR2866031B1 (fr) 2004-02-11 2004-02-11 Chimere de virus pathogene emergent, medicament la contenant et utilisation en therapie antivirale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0401364A FR2866031B1 (fr) 2004-02-11 2004-02-11 Chimere de virus pathogene emergent, medicament la contenant et utilisation en therapie antivirale

Publications (2)

Publication Number Publication Date
FR2866031A1 FR2866031A1 (fr) 2005-08-12
FR2866031B1 true FR2866031B1 (fr) 2012-10-19

Family

ID=34778688

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0401364A Expired - Lifetime FR2866031B1 (fr) 2004-02-11 2004-02-11 Chimere de virus pathogene emergent, medicament la contenant et utilisation en therapie antivirale

Country Status (1)

Country Link
FR (1) FR2866031B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1185615T3 (da) * 1999-04-06 2007-11-05 Wisconsin Alumni Res Found Rekombinante influenzavirus til vacciner og genterapi
DE122007000070I1 (de) * 1999-07-14 2008-01-31 Sinai School Medicine In Vitro-rekonstitution von segmentierten Negativstrang-Rna-Viren

Also Published As

Publication number Publication date
FR2866031A1 (fr) 2005-08-12

Similar Documents

Publication Publication Date Title
EE200400059A (et) Diarüültsükloalküülderivaadid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
PT1500654E (pt) Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos
DE60209779D1 (de) Sulfonamidderivate, deren herstellung und deren verwendung als medikamente
DK1542748T3 (da) Engangssprøjte
MA28512B1 (fr) Derive heterocyclique accole, composition medicamenteuse en contenant, et son utilisation medicamenteuse
FR11C0052I2 (fr) 8-[3-amino-piperidin-1-yl] -xanthines, leur production et leur utilisation comme medicament
IS7564A (is) Lyfjablanda með breytta losun
DE602005021501D1 (de) Sulfonamidderivate, ihre herstellung und ihre therapeutische anwendung
EE200100009A (et) Bensimidasoolid, nende valmistamine ja kasutamineravimitena
DK1773796T3 (da) Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf
EE200300193A (et) Asendatud bensimidasoolid, nende kasutamine ja ravim
DE60305037D1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
DE50308640D1 (de) Veterinärmedizinische spritze
MA29100B1 (fr) Dérivés de tétrahydrochinoline substituée par 4-cycloalkyle et leur utilisation comme médicaments
DE602006002887D1 (de) Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel
IL173004A0 (en) Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
DK1567137T3 (da) Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner
DE602004022010D1 (de) Sicherheitsspritze
FR2866031B1 (fr) Chimere de virus pathogene emergent, medicament la contenant et utilisation en therapie antivirale
FR2820311B3 (fr) Distributeur de medicament portatif
FI20021126A0 (fi) Antimikrobinen prepreg, komposiitti ja niiden käyttö
NO20002242D0 (no) Pustende, absorberende engangsartikkel
NL1027109A1 (nl) Verbinding en gebruik bij behandeling.
MA27172A1 (fr) 3-phenyl-5-alcoxy-1,3,4-oxdiazol-2-ones substitues, ainsi que leur production et leur utilisation dans des medicaments

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20